Symvess
NDC 83564-110, ACELLULAR TISSUE ENGINEERED VESSEL, implant, from Humacyte Global, Inc..
- Product NDC
- 83564-110
- Status
- Listed
- Labeler
- Humacyte Global, Inc.
- Dosage form
- IMPLANT
- Route
- INTRAVASCULAR
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA125812
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83564-110 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ACELLULAR TISSUE ENGINEERED VESSEL420 mm/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83564-110-00 | 83564011000 | 1 BOX in 1 BAG (83564-110-00) / 1 IMPLANT in 1 BOX (83564-110-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/15e9e29f-5aa6-4fc6-b0fe-a48cd1473418
Use it
Look up 83564-110 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83564-110 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83564-110. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.